Disclosures: Shunsuke Ikejima: Nothing to Disclose, Kazuyoshi Kon: Nothing to Disclose, Kumiko Arai: Nothing to Disclose, Akira Uchiyama: Nothing to Disclose, Hiroo Fukada: Nothing to Disclose, Kyoko Fukuhara: Nothing to Disclose, Reiko Yaginuma: Nothing to Disclose, Maki Morinaga: Nothing to Disclose, Masahiro Tada: Nothing to Disclose, SHUNHEI YAMASHINA: Nothing to Disclose, Kenichi Ikejima: Nothing to Disclose 627 FIBROBLAST GROWTH FACTOR 15/19 (FGF15/19) REGULATES CIRCADIAN ENERGY METABOLISM IN SHIFT WORKERS Zhenning Yang 1 Bo Kong 1 Mingzhu Fang 2 Rulaiha Taylor 1 Helmut Zarbl 1 Grace Guo 1 , 1 Rutgers University, 2 Bristol Myers Squibb Background: Chronic disruption of circadian rhythm by shift work is an important risk factor for metabolic diseases
Compounded GLP-1 medications represent a significant monthly expense
Funding This work was supported by grants from the Natural Science Foundation of Guangdong Province (2018A030313846 and 2021A1515012593), the Science and Technology Planning Project of Guangdong Province (2019A030317020), the National Natural Science Foundation of China (81802257, 81871859, 81772457, 82172750, 82172811, and 82260546), the Guangdong Basic and Applied Basic Research Foundation (GuangdongGuangzhou Joint Funds) (2022A1515111212), and the Science and Technology Program of Guangzhou (2023A04J1257)
From February 10-14th, we want to honor Wellstar healthcare heroes as Vital Valentinesthose dedicated to delivering world-class care to Georgia
it is obviously under the supervision of a professional pharmacist
Kratom (Mitragyna speciosa): user demographics, use patterns, and implications for the opioid epidemic